BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Rentschler Biopharma and Vetter Unveil Xpert Alliance

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that t...

March 29, 2022 | News

Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix®

Under the terms of the agreement, Xiel, a specialist distributor of Nuclear Medicine, Radiotherapy and Diagnostic Radiology technologies across the U.K. an...

March 29, 2022 | News

Singleron Acquires Proteona

Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their...

March 08, 2022 | News

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

CD34+ cell lots in a range of sizes also now available with high-resolution HLA information, eliminating the need for cumbersome and costly HLA screening...

March 08, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

March 03, 2022 | News

Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform

Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...

February 18, 2022 | News

Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries

Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted marketing authorization applications for ritonavir (100 mg film-coated tablet) in&n...

February 14, 2022 | News

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...

February 11, 2022 | News

X-Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets

Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates. This synergistic new partnership between Excelra&...

February 10, 2022 | News

Pfizer and Alex Therapeutics to provide evidence-based Digital Therapeutics to patients,

"In our efforts to give patients access to new, innovative forms of therapy, it is our aim to fully benefit from the possibilities of digitization. Alex Th...

February 01, 2022 | News

Eppendorf & Science Prize for Neurobiology 2022 Call for Entries!

This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...

January 19, 2022 | News

LumiraDx receives CE marking after successful CRP test

Quantitative results within 4 minutes of sampling facilitate rapid clinical decision-making at the point of care (POC) LumiraDx (Nasdaq: LMDX),...

January 12, 2022 | News

EU Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 Authorization follows po...

December 21, 2021 | News

UK medical diagnostics firm strikes commercial licensing deal to help Parkinson’s diagnosis in China

· Artificial intelligence and wearable technology invented in UK is helping to diagnose and manage Pa...

December 14, 2021 | News

Stay Connected